Novavax at the Floor: Collecting $0.31 While the Chart Finds Its Footing
Novavax has been a punching bag for the market lately — two consecutive Zacks headlines about the stock underperforming the broader market tells you everything about sentiment right now. But sentiment
Atlas Portfolio results referenced in this post are produced in a simulation environment using EOD market data and contract pricing. They are not records of trades placed in a brokerage account or executed with real capital, and individual results would vary based on fills, commissions, slippage, and account size. Tiblio is a software platform for finding and executing options trade ideas. We are not a registered investment advisor or broker-dealer. Nothing in this post is financial advice. Options trading involves substantial risk of loss. Past or simulated performance does not guarantee future results.